[125I]kisspeptin-14 (human) [7699]
[125I]kisspeptin-14 (human)
| SMILES | CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O |
| InChIKey | SWQFNQZATASWSZ-HCHFQKEFSA-N |
| Sequence | DLPNYNWNSFGLRF |
| HELM | PEPTIDE1{D.L.P.N.Y.N.W.N.S.F.G.L.R.F}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 22 |
| Hydrogen bond donors | 23 |
| Rotatable bonds | 51 |
| Log P | -5.765 |
| Molecular weight (Da) | 1741.8 |
| Stereochemistry info | unspecified |
| Radioactive | 125I |
No bioactivity data available.
[125I]kisspeptin-14 (human)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0